Language
Advances in Clinical and Health Sciences
Instructions for Authors
Currently Indexed By
Make a Submission
Publisher
Afrimvoe Medical Services
Carrefour Station Ola. Nouvelle Route Nkolbisson (N3)
P.O Box 17583 Yaounde - Cameroon
Editorial Team
HRA editorial team is lead by Pr Nko'o Amvene Samuel. Please, click here to see the whole team.
Recent Issues
In search of your work
The paper may have been published in our partner journal. Please, check on HSD website.
To get the off-print of the whole publication, please click on "pdf" below the title.
Our Partners
Endorsed by
Conseil Africain et Malgache pour l’Enseignement Supérieur (CAMES)
Follow us on social media
Statistics
Useful links
Browse
Information
EDITORIAL POLICIES
- Publication ethics and related editorial policies
HRA’s Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE) and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for HRA have been adapted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of HRA.
- Publication schedule
HRA is published monthly since 2024.
- Content licensing - Open access compliance
By default, articles published by HRA are Open Access and distributed under the terms of the Creative Commons Non-Commercial No-Derivatives License (CC BY-NC-ND 4.0). This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. CC BY-NC-ND includes the following elements:
- BY: credit must be given to the creator.
- NC: Only noncommercial uses of the work are permitted.
- ND: No derivatives or adaptations of the work are permitted.
- Copyright
The authors publishing under the Creative Commons Non-Commercial No-Derivatives License (CC BY-NC-ND 4.0). with HRA retain all rights, which means that the authors can read, print, and download, redistribute or republish (eg, display in a repository), translate the article (for private use only, not for distribution), download for text and data mining, reuse portions or extracts in other works, but they are not allowed to sell or re-use for commercial purposes, without asking prior permission from the publisher, provided the original work is properly cited.
- Peer review procedure
Research manuscripts are initially checked by the EIC or section editors for identification of gross deficiencies. At this stage, the proposal may be rejected. After this initial screening, articles (with supplementary material ) are made available to one or two-reviewers whose names are hidden from the author and whose review is guided by a checklist (single anonymized review) (https://b.link/peer-review. Author recommended reviewers are not allowed. The review summary is signed by the reviewer and is not posted with article. The review process may take days to weeks to reach a final decision that is the responsibility of the EIC. The duration from submission to publication may take one to six months (average: 6 months). So, the authors should avoid contacting the editorial office less than 6 weeks after the initial submission. The date of publication is published in the paper as well as dates of submission and acceptance.
- Author fees
Article submission is free of charges, but if your paper is accepted for publication, you will be asked to pay article processing charges (APC) to cover publications costs, depending on the type, complexity and length of the work, and on the number of authors. The minimum amount of APC is about 250 euros or 300 dollars or 150 000 XAF. If an author from a low revenue country does not have enough funds to pay such fees and the publication is a really worthy work, he may have an opportunity to partially waive each fee by asking the EIC.. APC are due before the accepted paper is published. Inquiries about fast track, manuscript status and preparation, as well as letters to the editor, should be directed to the Editor in Chief
